Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
111 results about "Myocardial oxygen consumption" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
High Reading– If the Myocardial Oxygen Consumption readings are higher than 4.244, this indicates an increased demand for oxygen. The degree of increased demand is based on your reading levels, i.e. mild, moderate >5.847 or severe 6.472.
Extractive of Taxus chinensis var.mairei leaves and preparation method
InactiveCN101716197AImprove microcirculationReduce myocardial oxygen consumptionConiferophyta medical ingredientsCardiovascular disorderDiseaseSolvent
The invention discloses an extractive of Taxus chinensis var.mairei leaves and a preparation method. The extractive is a straw yellow powder. The powder contains sciadopitysin the weight content of which is 65-70 percent; the sciadopitysin contains the following five components: 3-O-rutin-quercetol, 3-O-rutin-campherol, 3-O-rutin-myricetin, 7-O-glucose-campherol and 7-O-glucose-quercetol, and the total weight content of the five components in the sciadopitysin is 40-60 percent. The extractive is prepared by the preparation method comprising the steps of baking, crushing and screening, immersing into an alcohol dissolvant, ultrasonically extracting while stirring, decompressing and concentrating an extracting solution to remove alcohol, extracting with chloroform and degreasing, water phase concentrating and drying by taking fresh Taxus chinensis var.mairei leaves as raw materials. The extractive of Taxus chinensis var.mairei leaves has the functions of improving heat microcirculation, resisting arrhythmia, lowering myocardial oxygen consumption and the like and having the therapeutic and health-care function on diseases of cardiovascular system; and the preparation method has low energy consumption, short extracting time, few impurities and higher extraction efficiency.
Owner:宁波泰康红豆杉生物工程有限公司
Helicid soft capsule and its preparation method
InactiveCN1535690ALessen the severity of seizuresAlpha-wave exponential decreaseOrganic active ingredientsNervous disorderConvulsionSedative Effects
The present invention provides a helical soft capsule. Every capsule contains 5-200mg of helical, the rest is solvent matrix, the described solvent matrix is one of PEG 300-1000, propylene alcohol, soybean oil and peanut oil or their composition. According to the requirements the medicinal color matter and flavor agent can be added into its liquid medicine. Said invented soft capsule has the sedation, can obviously reduce coriamyrtin convulsion incidence rate, prolong its generative latent period, reduce frequency of attack and shorten the time and process of attack, and has the actions of stopping pain and resisting inflammation, and has a certain action of relieving vasoconstriction and raising oxygen consumption of heart muscle, and its biological utilization rate can be raised by 10-59%.
Owner:KUNMING ZIJIAN BIOTECH
Apparatus and method for measuring myocardial oxygen consumption
Owner:GUTIERREZ GUILLERMO
Pulsation type double-haematodocha heart auxiliary circulation device
The invention discloses a pulsation type double-haematodocha heart auxiliary circulation device. Two hydraulic chambers are arranged in a blood pump shell, a first haematodocha is connected with a second haematodocha through a one-way valve in the center of a baffle at the middle part of the blood pump shell, a first cavity is arranged between the first haematodocha and the blood pump shell, a hydraulic nozzle is arranged outside the first cavity and is communicated with a first pressure cavity through a pipeline, a second cavity is arranged between the second haematodocha and the blood pump shell, a hydraulic nozzle is arranged outside the second cavity and is communicated with a second pressure cavity through a pipeline, a piston is arranged between the first pressure cavity and the second pressure cavity and is connected with a silk pole mechanism installed on a servo motor through a connecting rod, and an embedded computer is respectively connected with a display and an operation keyboard. The invention has the advantages of lightening the heart load, lowering the myocardial oxygen consumption, enhancing the blood pressure in distole, promoting the cardiac pumping function, providing restoring environment to myocardial cells, stable work, reliable running, simple device and convenient operation.
Owner:RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
Somatic data-measuring apparatus and somatic data measurement method
InactiveUS20130231576A1Readily and accurately measureAccurately reflectPhysical therapies and activitiesInertial sensorsMeasurement deviceHeart sounds
Provided are a somatic data-measuring apparatus that can easily and accurately measure the optimal exercise intensity for the subject being measured, and a somatic data measurement method. The somatic data-measuring apparatus is provided with a heart sound-acquiring means that detects the subject's heart sounds and outputs same as heart sound data, a first heart sound-extracting means that detects the first heart sound on the basis of the heart sound data, a first heart sound amplitude-measuring means that measures the amplitude from the detected first heart sound and outputs same as first heart sound amplitude data, a heart rate-counting means that measures the subject's heart rate and outputs same as heart rate data, and an exercise intensity-computing means that computes the double product of the heart rate data and the first heart sound amplitude data as double product data and detects, as the optimal exercise intensity, the exercise intensity at which the approximation line, which approximates said double product data distribution, bends. Since the double product, which represents myocardial oxygen consumption, is effective as an index that accurately reflects the state of cardiac workload, it is possible to measure accurately the degree of workload on the heart.
Owner:FUKUOKA UNIV
Preparing and application of Yulangsan extract
InactiveCN101040894ASignificant effectNo side effectsNervous disorderDigestive systemSide effectCoronary heart disease
The invention relates to a method for extracting Yulang block to obtain Yulang water extractive, alcohol extractive, polysaccharide and chromocor. Researches have proved that the Yulang water extractive, alcohol extractive, polysaccharide and chromocor can stably reduce hypertension, restrain heart muscle retraction, reduce heart muscle oxygen consumption, improve coronary flux and reduce myocardial ischemia refill hurt, while it can release breath, release the asthma caused by acetylcholine simulation, and resist the retraction of acetylcholine or ergamine on bronchi. And the Yulang water extractive and polysaccharide can resist senile dementia and hepatitis or the like. The invention supplies a novel Chinese drug for treating hypertension, coronary disease, or the like, without side effect.
Owner:黄仁彬 +1
Apparatus and method for measuring myocardial oxygen consumption
Disclosed is a pulmonary artery catheter (“PAC”) that is used in determining myocardial oxygen consumption. Myocardial oxygen consumption is of critical importance because decreased myocardial energy utilization during acute illness may lead to tissue hypoperfusion, multiple organ failure, and eventually death. The inventor has discovered that myocardial oxygen consumption is a function of the difference in oxygen levels in atrial and mixed venous blood. The invention has further discovered that differences in lactate, glucose or any other measurable blood concentration metabolite in atrial or superior vena cava and mixed venous blood can also be used in determining myocardial oxygen consumption.
Owner:GUTIERREZ GUILLERMO
Cattail pollen extract and preparation process and use thereof
The present invention relates to a cattail pollen extract, its preparation method and its application. Its preparation method includes the following steps: using aqueous ethyl alcohol to make thermalextraction of typha poller, and adopting macroporous resin adsorption chromatographic process to obtain the invented typha pollen extract whose total flavone content is up to 50%. The animal tests show that it can obviously reduce extent of myocardial ischemia after ligation of canine coronary artery, can reduce the range of myocardial ischemia, can obviously reduce infarct range and can obviously reduce myocardial oxygen consumption, etc. so that it can be used for preparing medicine or food for preventing and curing angio cardiopathy due to myocardial ischemia.
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Traditional Chinese medicine preparation for purifying blood
InactiveCN101804110AGood hypolipidemic effectImprove solubilityAnthropod material medical ingredientsMetabolism disorderDiseasePropolis
The invention discloses a traditional Chinese medicine preparation for purifying blood, which comprises the following components: hawthorn, Astragalus root, leech, cortex moutan, safflower, hemlock parsley, suberect spatholobus stem, vinegar-radix paeoniae alba, angelica, trogopterus dung, salviae miltiorrhizae, propolis, calendula officinalis root, ginkgo leaf and gynostemma pentaphylla. The traditional Chinese medicine composite has the obvious effect of reducing blood lipid, can promote the decomposition of blood lipid, reduces blood viscosity, and resists atherosclerosis; the traditional Chinese medicine composite has the obvious effects of anticoagulation and anti-thrombosis, can inhibit the aggregation of thrombocyte, improves the activity of plasmin, and promotes fibrinolysis; the traditional Chinese medicine composite has favorable effects of heart strengthening, decompression and arrhythmia resistance, can slow heart rate, dilates coronary artery and blood vessel of brain, increases blood flow, lightens myocardial ischemic injury degree, lowers myocardial oxygen consumption, has obvious prevention effect on ischemic cerebrovascular diseases, can dilate peripheral vessel, reduces vascular resistance and promotes blood circulation; and the traditional Chinese medicine composite can promote the generation of haemoglobin and erythrocyte.
Owner:杨勤峰
Myocardial ischemia therapeutic instruments
ActiveCN101239222APayloadAddressing Adaptive IssuesArtificial respirationFrequency spectrumSpinal cord
The present invention provides a therapy instrument for myocardial ischemia, which is combined with power circuit, generation circuit of modulation wave, shaping circuit of modulation wave, modulation circuit, constant current source circuit, stimulating electrode, CPLD carrier generation circuit, carrier shaping circuit, output intensity control circuit and MCU. The therapy instrument has characters of non-invasive, non-pain sense electrical stimulation, overcoming body adaptability etc., and can treat patient with comfortable sense. The therapy instrument can assistant treat myocardial ischemia by skin spinal cord and fastigial nucleus electrical stimulation. The therapy instrument modulates the random signal of low-frequency slow change rhythm on the MF carrier signal with special spectrum structure by method of pulse amplitude modulation, and loads LF current to human skin spinal cord and fastigial nucleus with forms of current by surface electrode. The therapy instrument can treat myocardial ischemia by improving coronary blood flow, reducing myocardial oxygen consumption, controlling pain and protecting neurogenic neuroprotection.
Owner:CHONGQING UNIV +1
Apparatus and method for measuring myocardial oxygen consumption
The present invention relates to a method to determine a cardiac characteristic determined at a proximal end and a distal end of a pulmonary artery catheter. The present invention also relates to a method of treating a patient based on a determination of a determined difference between a cardiac characteristic a proximal end and a distal end of a pulmonary artery catheter.
Owner:GUTIERREZ GUILLERMO
Somatic data-measuring apparatus and somatic data measurement method
ActiveCN103298396AEasy to detectExact exercise intensityPhysical therapies and activitiesInertial sensorsHeart soundsCardiac muscle
Owner:FUKUOKA UNIV
Sedum aizoon L. tea
InactiveCN101816357AEnhance physical fitnessAvoid absorptionTea substituesLiver tissueLiver fibrosis
The invention relates to Sedum aizoon L. tea, which is prepared by using the following raw materials in percentage by weight: 70 to 85 percent of Sedum aizoon L. leaves, 11 to 30 percent of aloe leaves, 3 to 15 percent of ginseng leaves and 3 to 15 percent of folium cortex eucommiae, optimally 76 percent of Sedum aizoon L. leaves, 18 percent of aloe leaves, 3 percent of ginseng leaves and 3 percent of folium cortex eucommiae. Sitosterol in the Sedum aizoon L. tea can prevent the cholesterol absorption of human bodies, reduce blood fat and prevent angiosclerosis; flavones in the Sedum aizoon L. tea can expand blood vessels, promote blood circulation and reduce myocardial oxygen consumption; and oleanolic acid in the Sedum aizoon L. tea can protect liver tissues and prevent liver fibrosis. The Sedum aizoon L. tea can be drunk for a long time for strengthening body, preventing arteriosclerosis and heart diseases, protecting the liver and delaying aging.
Owner:肖永英
Medicine for treating ischemic angiocardiopathy and cerebrovascular disease and its preparation method
InactiveCN1413655AImprove blood and oxygen supplyBlood supply and oxygen supply adjustmentUnknown materialsCardiovascular disorderDiseaseAcute myocardial ischaemia
A Chinese medicine for treating ischemic cardiovascular and cerebrovascular diseases is prepared from 3 Chinese-medicinal materials ginseng, red sage root and corydalis tuber through extracting, separating by adsorptive resin, eluting and concentrating. Its advantages are high curative effect and low cost.
Owner:刘建勋
Medicine for treating cardiovascular and cerebrovascular diseases
PendingCN105617355ALower triglyceridesLower total cholesterolOrganic active ingredientsPeptide/protein ingredientsDiseaseSide effect
The invention provides medicine for treating cardiovascular and cerebrovascular diseases. The medicine is glycoprotein, mixture of polysaccharide and protein, polypeptide or protein. The medicine has the advantages that the triglyceride and total cholesterol contents of rats can be lowered effectively; the anoxia survival time of mice can be prolonged to reach 70-85 minutes; the microcirculation can be improved, the coronary artery can be expanded, the myocardial blood supply can be improved, the blood flow of the brain and the coronary artery can be increased, the heart rate can be reduced, and the myocardial oxygen consumption index can be lowered to improve myocardial blood metabolism, resist thromboxane, increase high-density lipoprotein, resist vasospasm and reduce platelet aggregation, and the total cholesterol and triglyceride of the blood can be lowered; the medicine is safe, efficient and free of side effect.
Owner:徐宝贞
Novel sea buckthorn tea and making method thereof
InactiveCN106359759ARetain nutrientsRich in nutrientsPre-extraction tea treatmentTea substituesBlack teaPlatelet inhibition
The invention discloses novel sea buckthorn tea and a making method thereof and belongs to the field of tea processing. The novel sea buckthorn tea is sea buckthorn black tea made by subjecting sea buckthorn leaf to black tea making process; the novel sea buckthorn tea may be made into sea buckthorn Fuzhuan tea by subjecting sea buckthorn leaf to Fuzhuan tea making process among black tea making processes, wherein certain raw black tea may be added during making of the sea buckthorn Fuzhuan tea. According to the novel sea buckthorn tea and the making method thereof provided herein, sea buckthorn leaf is used as a raw material effectively combined with the black tea making process, rich nutrients in the sea buckthorn leaf are retained, sea buckthorn leaf fermentation and moldy spot appearing are achieved, and the produced sea buckthorn black tea is imparted the effects such as increasing coronary artery blood flow, reducing cardiac oxygen consumption, suppressing platelet aggregation, lowering blood pressure, lowering blood lipid, and lowering blood glucose; the produced sea buckthorn Fuzhuan tea is rich in Eurotium cristatum and has the effects such as resisting tumors, adjusting immunity, delaying senility, clearing heat and toxicity, and invigorating stomach to improve appetite.
Owner:郑文利 +1
Nifedipine medicine composition and preparation method thereof
InactiveCN102370644AHigh dissolution ratePromote absorptionOrganic active ingredientsPharmaceutical non-active ingredientsChronic stable anginaPeripheral resistance
The invention discloses a nifedipine medicine composition and a preparation method thereof. The nifedipine medicine composition contains nifedipine, hydroxymethyl propyl cellulose and microcrystalline cellulose. The hydroxymethyl propyl cellulose is used as slow-releasing framework material; the weight ratio of the nifedipine and the hydroxymethyl propyl cellulose is 2:1-1:1; and the weight ratio of the nifedipine and the microcrystalline cellulose is 1:4-1:3; and lactose, starch, calcium hydrophosphate and glucose can be also added. The method for preparing the nifedipine medicine composition comprises the following steps of: (1) crushing and screening; (2) drying; and (3) tabletting. According to the invention, the dissolution rate of the nifedipine in the water can be increased, the coronary arteries in the normal blood supply area and the ischemic area are relaxed while the absorption rate of the nifedipine in the body is increased so that coronarospasm and is released and prevented and myocardial contraction is inhibited; myocardial oxygen consumption is reduced; the peripheral resistance is released; after load of heart is reduced; sinus node function and atrioventricular conduction of the isolated heart are slowed down; and the nifedipine medicine composition is applicable to variant angina pectoris, unstable angina pectoris and chronic stable angina pectoris.
Owner:JILIN AODONG GROUP DALIAN PHARMACEUTICAL CO LTD
Health-care product for improving cardiovascular and cerebrovascular symptoms
InactiveCN101628058APromote circulationFree radical scavengingSenses disorderAntineoplastic agentsDiseaseVegetable oil
The invention discloses a health-care product for improving cardiovascular and cerebrovascular symptoms, belonging to the field of medical technology. The health-care product comprises the following components: 80-110mg of kudzuvine root extract, 15-20mg of grape seed extract, 360-400mg of refined vegetable oil, 230-260mg of gelatin and 100-125mg of glycerin. The health-care product has favorable effects of improving cardiovascular and cerebrovascular diseases, dilating blood vessels, improving blood circulation, reducing myocardial oxygen consumption, inhibiting cancer cells, increasing coronary blood flow, adjusting blood microcirculation, and treating sudden deafness of persons at different ages.
Owner:RHK GROUP
Method for preparing composite enzyme of kudzu vine leaves and folium mori
ActiveCN105962344AQuality improvementFully retain active ingredientsFood ingredient functionsBlood vesselEnzyme method
The invention discloses a method for preparing composite enzyme of kudzu vine leaves and folium mori. The method comprises the following steps of: shredding kudzu vine leaves and folium mori, squeezing, collecting a leaf liquid, pouring the squeezed kudzu vine leaves, the folium mori and the leaf liquid into a fermentation container, adding a sodium hydrogen phosphate-citrate buffer solution which is cooled in advance, adding composite enzyme and ferrous carbonate, and performing enzyme method low-temperature extraction; and preparing primary fermentation broth from the extraction filtrate, inoculating the primary fermentation broth into lactobacillus plantarum so as to obtain secondary fermentation broth, and performing solid-liquid separation on the secondary fermentation broth, thereby obtaining the composite enzyme. Due to enzyme method low-temperature extraction, nutrient elements in kudzu vine leaves and folium mori can be sufficiently extracted, and thus the effects and eating security of the product can be greatly improved; the method disclosed by the invention is simple in process, effective components of kudzu vine leaves and folium mori can be sufficiently maintained, the quality is stable, multiple effects of reducing blood vessel resistance, improving heart and brain blood circulation, reducing myocardial oxygen consumption and the like can be achieved, and a nutrient healthcare function can be achieved.
Owner:JIANSU MAOBAO GEYE CO LTD
Corynoxeine and application of isomer thereof in preparing medicines
InactiveCN101991573ARaise the excitement thresholdAccurate massOrganic active ingredientsMetabolism disorderVentricular tachycardiaAngina
The invention belongs to the traditional Chinese medicine field, and relates to corynoxeine and an application of an isomer of the corynoxeine in preparing medicines. In the invention, the results of animal experiments prove that the corynoxeine and the isomer thereof have the effects of expanding vessels and lowering blood pressure, and can be used for preparing the medicines for expanding the vessels and lowering the blood pressure; the corynoxeine and isocorynoxeine have the effects of expanding the vessels, lowering heart afterload, lightening heart burden and decreasing myocardial oxygen consumption, and can be used for preparing anti-angina pectoris medicines; the corynoxeine has the effects of negative myodynamia, directly decreasing the myocardial oxygen consumption, and doubly lowering the myocardial oxygen consumption; the corynoxeine and the isocorynoxeine have the effects of improving the ventricular muscle excited threshold and lowering the ventricular muscle contraction frequency, can be used for treating ventricular tachycardia, and can be used as a quality identification uncaria and tagged molecules of the ffective parts of the corynoxeine and the isocorynoxeine.
Owner:FUDAN UNIV
Abelmoschus manihot flower tea
InactiveCN106135585AOvercome effectivenessOvercome the disadvantages of patternTea substituesHibiscusBiology
The invention discloses Abelmoschus manihot flower tea. The Abelmoschus manihot flower tea is mainly produced by drying Abelmoschus manihot through a hot-air gradient drying method. The hot-air gradient drying method specifically includes: drying at 60-67 DEG C for 57-98 minutes; drying at 49-59 DEG C for 126-187 minutes; drying at 41-48 DEG C for 214-248 minutes; drying at 34-40 DEG C for 275-310 minutes. The Abelmoschus manihot flower tea has the advantage that the hot-air gradient drying can keep more biological active substances which have effects of beautifying, nourishing, regulating body immunity, lowering myocardial oxygen consumption, increasing blood quantity of coronary arteries and brain blood vessels and improving blood circulation in the Abelmoschus manihot flower tea.
Owner:许备占
Health-care Chinese hawthorn leaf tea capable of reducing glucose and lipid and preparation method of tea
ActiveCN103734425AAbundant resourcesWide range of pharmacological effectsMetabolism disorderTea substituesPharmacologic actionOfficinalis
The invention provides a health-care Chinese hawthorn leaf tea capable of reducing glucose and lipid. The health-care Chinese hawthorn leaf tea capable of reducing glucose and lipid comprises the following raw materials in parts by weight: 10-50 parts of Chinese hawthorn leaves, 10-20 parts of cortex magnoliae officinalis, 10-20 parts of albizia julibrissin, 10-20 parts of Chinese mosla herb, 10-20 parts of polygonatum kingianum, 10-20 parts of dried radix rehmanniae, 10-20 parts of cortex albiziae, 10-20 parts of lalang grass rhizome, 10-20 parts of poria cocos, 10-20 parts of salviae miltiorrhizae, 10-20 parts of mulberries, 10-20 parts of fortune eupatorium herb, 10-20 parts of gynostemma pentaphyllum, 10-20 parts of cortex mori radicis, 10-20 parts of cortex moutan, 10-20 parts of astragalus, 10-20 parts of coix seeds, and 10-20 parts of inula japonica. The Chinese hawthorn leaf flavonoid contained in the Chinese hawthorn leaves has a wide pharmacologic action, is especially beneficial to a cardiovascular system, has the pharmacologic actions of reducing blood pressure, reducing peripheral vascular resistance, expanding coronary artery, increasing coronary flow, reducing myocardial oxygen consumption, strengthening the heart, increasing cardiac output, resisting myocardial ischemia and platelet aggregation, improving blood rheology, removing oxygen radical, enhancing hypoxia tolerance, inducing dieresis and the like.
Owner:河北森隆医药科技有限公司
Lobed kudzuvine root healthcare tea
InactiveCN104381542APromote circulationImprove immunityPre-extraction tea treatmentTea substituesHeart muscle extractMedicine
The invention discloses lobed kudzuvine root healthcare tea which comprises the following components in parts by weight: 100 parts of dried lobed kudzuvine root chips and 10-70 parts of dried lobed kudzuvine root leaves. The dried lobed kudzuvine root chips and the dried lobed kudzuvine root leaves are crushed and mixed. The lobed kudzuvine root chips of the healthcare tea disclosed by the invention contain a relatively great amount of flavonoids compounds, has multiple healthcare functions of expanding coronary artery blood vessels and brain vessels, reducing the myocardial oxygen consumption, improving the myocardial contraction functions, promoting blood circulation, improving the human body immunity and the like, and is simple in preparation process and good in healthcare effect.
Owner:罗英明
Medicinal composition containing nitrate esters for treating ventricular hypertrophy or myocardial fibrosis
ActiveCN101120939AEasy to acceptSimple route of administrationEster active ingredientsHeterocyclic compound active ingredientsCoronary artery diseaseTreatment effect
Myocardial hypertrophy is a pathological change of a plurality of kinds of angiocardiopathy. The main mode is the heart remodeling comprising cardiac muscle cell hypertrophy and change of the interstitial tissue component mainly. In the present invention, the nitrate medicine is used in treatment for myocardial hypertrophy caused by various reasons and excellent therapy effect is obtained. Currently the nitrate medicine is extensively applied in treatment for the coronary heart disease, the heart colicky pain and heart failure. Preload of the heart and myocardial consumption of oxygen are reduced by extension of the venous system. The drugs used in clinical field currently comprise Nitroglycerin, Amyl Nitrite, dicho nitric acid sorbite, sorbide dinitrate, 5-isosorbide dinitrate, Nitroglycerin, pentanitrol ters and itramine tosylate.
Owner:LUNAN PHARMA GROUP CORPORATION
Use of benzisoselenazolone compounds against ischemic myocardial damage
InactiveUS20060135569A1Improve the protective effectImprove latencyBiocideOrganic chemistryCoronary arteriesMedicine
The invention discloses use of benzisoselenazolones, particularly compounds represented by the general formula (I) against ischemic myocardial injury. The compounds are characterized by selectively inhibiting Na+ / Ca2+ exchange, dilating coronary artery and decreasing myocardial oxygen consumption, which possess the advantages of high activity, potent specificity and low toxicity.
Owner:INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
Traditional Chinese medicine composition for treating coronary heart disease
ActiveCN102961529AAntispasmodicWith priorityCardiovascular disorderPlant ingredientsSide effectCoronary artery disease
A traditional Chinese medicine composition for treating coronary heart disease provided by the invention belongs to the technical field of Chinese herbal medicine. The invention aims to solve a technical problem by providing a traditional Chinese medicine for treating coronary heart disease and angina, and the medicine can effectively treat angina, and has no obvious side effects, and strong compliance to patients. A technical scheme is as below: 20-90 parts of Astragalus mongholicus, 20-30 parts of root of red-rooted salvia, 6-9 parts of Hirudo powder, 15-20 parts of Ligusticum wallichii, 9-12 parts of safflower, 12-25 parts of root of common peony, 6-9 parts of pseudo-ginseng, 20-30 parts of rhizoma acori graminei, 10-25 parts of rhizoma corydalis, 9-20 parts of long pepper, 9-15 parts of scorpion, 1-3 parts of centipede, 9-15 parts of stiff silkworm, and 20-50 parts of root of kudzu vine. The medicine provided by the invention has effects of promoting blood circulation to remove blood stasis and activating meridians to stop pain, and not only can dilate coronary artery, increase blood flow, reduce myocardial oxygen consumption, but also has effect of easing coronary spasm.
Owner:临汾市汇友创电子科技有限公司
Traditional Chinese medicine for reducing blood fat and preparation method
InactiveCN104857506AGood blood fat-lowering effectSimple prescriptionPeptide/protein ingredientsMetabolism disorderPolygonum fagopyrumAdemetionine
The invention belongs to the field of medicine production, in particular to a traditional Chinese medicine for reducing blood fat and a preparation method. The traditional Chinese medicine for reducing blood fat is prepared from raw materials in parts by weight as follows: 10-30 parts of natural hirudin, 8-20 parts of seafish oil preparations, 12-18 parts of danshen roots, 10-15 parts of cassia seeds, 5-10 parts of ginger powder, 3-8 parts of tartary buckwheat, 5-16 parts of hawthorn fruit and 5-10 parts of kudzuvine roots. The traditional Chinese medicine has the benefits and the technical effects as follows: the composition has better efficacy of blood fat reduction and is cheap, and the formula is simple; according to modern traditional Chinese medicine extraction, separation and preparation technologies, a reasonable preparation can be prepared from the traditional Chinese medicine composition; the traditional Chinese medicine can expand blood vessels, promote blood circulation, increase coronary perfusion flow and reduce myocardial oxygen consumption, and the treatment functions of auxiliary blood pressure reduction and blood fat reduction are comprehensively realized. The medicine composition is an elaborately-developed product in combination of traditional Chinese medicine medical skill and modern crafts in long-term practice and has a good effect on reduction of blood fat and blood pressure.
Owner:ZHANGJIAGANG WUHU NEW MATERIAL TECH DEV
Pharmaceutical composition for treating dorking abdominal dropsy caused by high natrium
InactiveCN101683425AEliminate side effectsIncrease contractilityOrganic active ingredientsBlood disorderLiver and kidneySide effect
The invention relates to a pharmaceutical composition for treating dorking abdominal dropsy caused by high natrium, which is prepared by uniformly mixing the following components by weight: 50-400 mgof digitalis leaf ultrafine powder, 10-100 mg of triamterene and 50,000 mg of glucose. In the invention, the digitalis leaves contain digitoxin, thereby strengthening the myocardial contraction force,increasing the cardiac output and also slowing the heart rate and reducing the myocardial oxygen consumption so that heart-failure heart functions are improved; the digitalis leaf ultrafine powder isbeneficial to absorbing, thereby reducing the dosage and the side effects of medicaments and enhancing the treatment effect; the triamterene increases the discharge amount of natrium and chlorine soas to be diuretic, thereby being more suitable for heart-failure dorkings; in addition, the glucose improves the requirement of important organs of organisms for sugar in a high natrium state, therebybeing benefit to the detoxifying function of liver and kidney. The pharmaceutical composition is simple, has reasonable preparation and plays a good role in treating the dorking abdominal dropsy caused by the high natrium contained in the feeds or drinking water after being added to dorking feeds per kilogram.
Owner:TIANJIN SHENGJI GRP CO LTD
Total extractives of steroid saponin, prepn. method and application thereof
InactiveCN1830998AGood effectReduce oxygen consumptionOrganic active ingredientsSkeletal disorderDiseaseRheumatism
The invention relates to extract of the steroid saponin produced from the yam or the yam with the guilder leaf which has the character of containing the 80%-90% the steroid saponin in the percentage by weight. The intravenous fluid produced from the extract of the steroid saponin can not only dilate the coronary, depress the myocardial oxygen consumption, melt the thrombus, improve the myocardial ischemia and the microcirculation, amend the function of the vas endothelial cell, increase the blood stream of the brain, prevent the ischemia brain cell injury, but also drop the blood pressure, the blood fat, the blood sugar; at the same time, it has the function of resisting inflammation, ease pain, codein, preventing asthma, dispelling the myospasm, improving the immunity and resisting the allergy. So it can cure the cerebrovascular, the rheumatism and the disease of the respiratory system. The invention has the good clinic extended value because of the low dosage of the active ingredient, the efficacy, the effecting quick and the high bioavailability.
Owner:青岛浩普医药研究有限公司
Method of making hawthorn dried tofu
InactiveCN103262900AReduce oxygen consumptionFavorable gastrointestinal motilityCheese manufactureFood scienceSalvia miltiorrhizaAdditive ingredient
The invention discloses a method of making hawthorn dried tofu, which comprises the following raw materials in parts by weight: 1000-1200 of soybeans, 10-12 of asparagus, 10-12 of brasenia schreberi, 40-45 of hawthorn, 10-15 of salvia, 10-12 of equisetum, 10-12 of Petasites tatewakianus Kitam, 10-12 of angelica, 10-12 of cress, 10-12 of pumpkin flower, 5-8 of Cinquefoil, 20-30 of pepper, 5-8 of overlord flower, 10-12 of rose-boot, 10-12 of polygonatum, 10-12 of lentinus edodes, 10-12 of mulberry leaf , 8-10 of lily, 8-10 of cherokee rose, 5-8 of perilla leaf, 3-6 of radix bupleuri, 3 -4 of sugarcane top, and 3-6 of flasem milkvetch seed. Compared with the prior art, the invention adds a variety of wild vegetables and edible Chinese medicine ingredients. The hawthorn can promotes digestion, lower blood fat, increase coronary blood flow, reduce myocardial oxygen consumption, and has a protective effect on myocardial ischemia and oxygen deficit. Meanwhile, the invention adopts multiple grinding processes, which reduces the bean dregs and adds the dietary fiber of bean dregs to the soybean milk, improving gastrointestinal peristalsis to help defecation.
Owner:QINGYANG QUNYING GREEN FOOD DEV
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com